Valeant buys Mexican branded generics from Atlantis Pharma
This article was originally published in Scrip
Executive Summary
Valeant Pharmaceuticals said it will acquire assets from Altantis Pharma, a branded generics pharmaceutical company, for about $71 million, in order to expand its reach in Mexico.